Natural history of small radioiodine-avid bone metastases that have no structural correlate on imaging studies

[1]  D. Glazer,et al.  SPECT/CT evaluation of unusual physiologic radioiodine biodistributions: pearls and pitfalls in image interpretation. , 2013, Radiographics : a review publication of the Radiological Society of North America, Inc.

[2]  J. Shah,et al.  The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland. , 2012, Thyroid : official journal of the American Thyroid Association.

[3]  R. Tuttle,et al.  Skeletal-related events due to bone metastases from differentiated thyroid cancer. , 2012, The Journal of clinical endocrinology and metabolism.

[4]  Kiyoshi Ichihara,et al.  Prognostic Factors for Recurrence of Papillary Thyroid Carcinoma in the Lymph Nodes, Lung, and Bone: Analysis of 5,768 Patients with Average 10-year Follow-up , 2012, World Journal of Surgery.

[5]  B. Ahn,et al.  False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer. , 2012, American journal of nuclear medicine and molecular imaging.

[6]  Quan-Yong Luo,et al.  Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer. , 2011, The Journal of clinical endocrinology and metabolism.

[7]  M. Ringel.  Metastatic dormancy and progression in thyroid cancer: targeting cells in the metastatic frontier. , 2011, Thyroid : official journal of the American Thyroid Association.

[8]  I. Sugitani,et al.  Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma. , 2010, Surgery.

[9]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[10]  E. Hindié,et al.  Bone Metastases of Differentiated Thyroid Cancer: The Importance of Early Diagnosis and 131I Therapy on Prognosis , 2008, Journal of Nuclear Medicine.

[11]  R. Zarnegar,et al.  Bone metastases from differentiated thyroid carcinoma. , 2008, Endocrine-related cancer.

[12]  E. Hindié,et al.  Bone metastases of differentiated thyroid cancer: impact of early 131I-based detection on outcome. , 2007, Endocrine-related cancer.

[13]  T. Fahey.  Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy , 2007 .

[14]  E. Baudin,et al.  Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. , 2006, The Journal of clinical endocrinology and metabolism.

[15]  F. Cetani,et al.  Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine , 1994, World Journal of Surgery.

[16]  G. Zettinig,et al.  Long‐term follow‐up of patients with bone metastases from differentiated thyroid carcinoma – surgery or conventional therapy? , 2002, Clinical endocrinology.

[17]  G. Hejblum,et al.  Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. , 2001, The Journal of clinical endocrinology and metabolism.

[18]  T. Petrich,et al.  Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side-effects and influence of age , 2001, European Journal of Nuclear Medicine.

[19]  S. Larson,et al.  Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. , 2000, Thyroid : official journal of the American Thyroid Association.

[20]  J. Juang,et al.  Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. , 1999, Thyroid : official journal of the American Thyroid Association.

[21]  M Magnano,et al.  Lymphnode metastasis in head and neck squamous cells carcinoma: multivariate analysis of prognostic variables. , 1999, Journal of experimental & clinical cancer research : CR.

[22]  M. Schlumberger,et al.  Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  C. Marcocci,et al.  Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma. , 1989, Surgery.

[24]  E. Bergstralh,et al.  Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. , 1988, The Journal of clinical endocrinology and metabolism.

[25]  B. Caillou,et al.  Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. , 1986, The Journal of clinical endocrinology and metabolism.

[26]  W. Beierwaltes,et al.  Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.